anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

225,241-225,300 of 319,975

filter-aware
03
The slide uses a hub-and-spoke diagram to connect the company brand to three core pillars: team, portfolio, and financials.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · SetupLoop · Cost Of Inaction1 hit
04
SAB stands for Scientific Advisory Board.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · SetupLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style chart to represent clinical trial progress.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · SetupLoop · Cost Of Inaction1 hit
06
The diagram illustrates a biological signaling pathway with specific nodes highlighted as targets for therapeutic intervention.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
07
The slide uses a matrix structure to map clinical assets to specific indications and trial names.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
08
The diagram shows the MAPK pathway inhibition. The patient population data is presented as a simple table.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
09
The slide uses a KINOMEscan visualization to show selectivity.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
10
The chart is a classic waterfall plot used in oncology to show best response per patient/model.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Complication1 hit
11
The slide combines a biological pathway diagram with a clinical trial summary table to demonstrate clinical validation.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
12
The slide uses a side-by-side comparison of two market segments, each with a big number metric and supporting clinical/regulatory context.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
13
Includes a biological diagram illustrating the RAS protein state transition and mutation impact.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
14
The chart shows lower IC50 values for the Q61X mutation group, suggesting higher sensitivity to the drug.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
15
Waterfall plots showing best percentage change from baseline for two distinct patient cohorts.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
16
Includes a Kaplan-Meier survival curve comparing existing standard-of-care options.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
17
The slide uses a 'before-after' visual comparison to demonstrate clinical efficacy.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
18
The slide highlights US FDA Fast Track designation and superior PFS performance.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
19
The chart is a mirrored bar chart (diverging bar chart) showing AE frequency by grade.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
20
The slide uses a 2D grid to map dose combinations against regulatory requirements (Project Optimus).Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
21
The slide outlines two distinct clinical trial programs (SEACRAFT-1 and SEACRAFT-2) with specific stages, patient cohorts, and regulatory endpoints.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
22
The diagram shows the RAS/MAPK signaling pathway with ERAS-007 targeting ERK.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
23
Erasca | Investor Presentation Deck | 41 slidesErasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
24
The chart is a Kaplan-Meier survival curve comparing a control arm to an experimental arm (EC).Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
25
Shows efficacy data for ERAS-007 in combination with Encorafenib and Cetuximab.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
26
Includes waterfall plot and swimmer plot for clinical trial results.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
27
Data cutoff 23MAR2023. TRAE = Treatment-related Adverse Event. EC = Encorafenib + Cetuximab.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
28
The diagram shows the RAS/MAPK/PI3K signaling pathway. ERAS-801 is shown as an EGFR inhibitor.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
29
The slide uses a stacked bar chart to show mutation incidence and a comparison table to highlight clinical trial failures in GBM compared to other indications.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
30
The slide uses a biological diagram to illustrate EGFR mutations in GBM.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
31
The slide uses western blot data to demonstrate potency and a table to demonstrate pharmacokinetic superiority in mouse models.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
32
The chart is a Kaplan-Meier survival plot comparing three treatment groups.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
33
The diagram illustrates a standard 3+3 or similar dose escalation design leading to an MTD and subsequent safety expansion.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
34
Erasca | Investor Presentation Deck | 41 slidesErasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
35
Erasca | Investor Presentation Deck | 41 slidesErasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
36
Features the Lorenz attractor graphic, which is a signature visual for Erasca.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
37
The table uses a heatmap-style color coding where red indicates red ocean opportunities and teal/green indicates blue ocean opportunities.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
38
The slide uses a two-column layout (Preclinical vs Clinical) to position the company's lead asset against competitors.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
39
The slide uses a comparative framework to contrast the 'Terminated' vs 'Clinical' status of competitors, with a callout box detailing the specific advantages of ERAS-007.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations 1 hit
40
The slide uses western blot imagery to show protein expression levels (P-RSK, P-ERK, GAPDH) over time (0-72h) to prove the efficacy of ERAS-007.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations 1 hit
41
The slide uses a log-scale line chart for PK profiles and a summary table for key metrics (Cmax, Cmin, T>IC90, T<IC50).Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations 1 hit
01
Slide 1
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Setup1 hit
02
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Setup1 hit
03
The slide emphasizes inclusivity and global reach.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Setup1 hit
04
The slide uses a split-screen layout with a solid magenta background on the left and a group photo on the right.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · Setup1 hit
05
The slide uses a high-impact visual style with brand imagery and logos (Libresse, Saba, Bodyform) to reinforce the corporate identity.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
06
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
07
The slide uses a donut chart progression to illustrate strategic portfolio rebalancing.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
08
The slide uses a background image of people to convey a brand-focused message, with a white overlay containing the logos.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
09
Uses a waterfall chart to explain sales growth and circular callouts for key performance indicators.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
10
The slide uses bar charts to visualize financial performance trends.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
11
The slide uses two bar charts to visualize financial performance over a decade.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
12
The slide uses a callout circle to emphasize the current proposed dividend and an arrow overlay to visualize the growth trend.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
13
The slide uses a grid of circular callouts to present financial KPIs.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
14
The chart uses a standard waterfall bridge format to explain sales growth components.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
15
The chart uses a waterfall-bridge structure to explain margin variance.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
16
The slide serves as a visual transition to the Health & Medical segment of the presentation.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
17
The waterfall chart uses a break in the axis to represent the growth components between the two net sales bars.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
18
The slide serves as a visual transition to the Consumer Goods section of the presentation.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
19
Uses a waterfall-bridge chart to explain the change in Net Sales.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
20
Essity | Results Presentation Deck | 30 slidesEssity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit
21
The slide uses a waterfall-style bridge to explain sales growth, followed by two circular callouts for profitability metrics.Essity | Results Presentation Deck | 30 slides · Essity
Conference presentation Investor relations Beat · DevelopmentLoop · Pareto Focus1 hit